ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020

Neoadjuvant or Adjuvant Therapy for Resectable or Borderline Resectable Pancreatic Cancer: Which Is Preferred?

Eileen M O'Reilly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.